Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Clinical trial NCT00042952 · TERMINATED

Trial details

NCT number: NCT00042952
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Dysgerminoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage II Malignant Testicular Germ Cell Tumor Stage II Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Testicular Seminoma

Start date: 2002-06-01
Primary completion: 2003-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.